1. FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles
   Zhi Yang et al, 2017, Therapeutic Advances in Medical Oncology CrossRef
2. Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis
   Tania Ray et al, 2021, Frontiers in Oncology CrossRef
3. Improved identification of core biomarkers and drug repositioning for ovarian cancer: an integrated bioinformatics approach
   Md Shahjaman et al, 2020, Network Modeling Analysis in Health Informatics and Bioinformatics CrossRef
4. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway
   Souvik Mukherjee et al, 2022, Cancers CrossRef
5. The long noncoding RNA FOXCUT promotes proliferation and migration by targetingFOXC1in nasopharyngeal carcinoma
   Yu-zhong Xu et al, 2017, Tumor Biology CrossRef
6. The Diverse Consequences of FOXC1 Deregulation in Cancer
   L. Niall Gilding et al, 2019, Cancers CrossRef
7. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis
   Md. Alim Hossen et al, 2023, Current Cancer Drug Targets CrossRef
8. circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade
   San-Gang Wu et al, 2021, Cancer Cell International CrossRef